Teosyal RHA Collection
Resilient Hyaluronic Acid (RHA) technology for movement-following natural results | RHA1-RHA4
About This Treatment
Teosyal RHA (TEOXANE, Switzerland) uses innovative RHA (Resilient Hyaluronic Acid) technology. Unlike traditional cross-linked HA, RHA's linear molecular network is more flexible, following facial muscle movement while smoothing wrinkles. First and only FDA approval for "Dynamic Wrinkles."
[RHA1] Ultra-fine lines (periocular). [RHA2] Mild dynamic wrinkles (forehead, glabella). [RHA3] Moderate volume loss (nasolabial). [RHA4] Deep volume loss and skeletal augmentation.
Mechanism of Action
RHA technology connects HA molecules in a unique cross-linking pattern with greater flexibility than rigid traditional HA networks. During facial muscle contraction, RHA absorbs stress and deforms, following natural facial dynamics while smoothing dynamic wrinkles. Results in natural appearance without frozen look. Includes collagen-induction effects from HA degradation.
Indications
Expected Results
Most natural improvement for dynamic wrinkles. RHA1/RHA2 lasts 9-12 months, RHA3/RHA4 12-18 months. High patient satisfaction with "wrinkles move naturally."
Clinical Evidence
Risks & Side Effects
Injection swelling/bruising (1-2 weeks). RHA FDA-approved with excellent safety. Rare vascular occlusion. No RHA-specific risks reported. Reversible with hyaluronidase.
Interested in this treatment?
Start with an AI skin analysis to check your current skin condition